Tim Herman, Managing Director, Seven Stones
October 15, 2009Medical Communications appointment, medical communications, seven stones
Tim Herman has joined independent healthcare specialist Seven Stones as managing director, after six years running Ogilvy Healthworld Advertising.Tim has …
CME Spotlight: Moving CME forward in Europe
October 15, 2009Medical Communications CME, CME Spotlight, Eugene Pozniak, ethics
As a young advertising account exec in the early nineties I was once told not to concern myself with any …
Tamiflu windfall helps Roche to bumper sales growth
October 15, 2009Sales and Marketing Roche, Tamiflu
Roche has raised its sales growth prediction for 2009 on the back of a strong third quarter and record sales …
Huntsworth Health reshuffles global operations
October 15, 2009Medical Communications Huntsworth, Tonic
Healthcare marketing and communications agency Huntsworth Health is reorganising its global operations.Part of Huntsworth plc, it will be split into …
Pfizer completes Wyeth merger
October 15, 2009Sales and Marketing MA, Pfizer, restructure
Pfizer expects to complete its $68 billion acquisition of Wyeth today after receiving sign-off on the deal from regulators in …
US health reform clears first hurdle
October 14, 2009Sales and Marketing Obama, Senate, US, US healthcare, hc, reform
The US Senate has approved the bill to reform America’s health care system, raising hopes that it can become law …
GSK plans
October 14, 2009Research and Development GSK
GlaxoSmithKline, the government and the Wellcome Trust are collaborating to build what they hope will be a "world-class" science park. …
Merck makes Indian bioscience acquisition
October 14, 2009Research and Development Asia, India, Merck
Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …
Hospira takes charge of biogeneric Neupogen
October 14, 2009Sales and Marketing Hospira, biosimilars, generics
US pharmaceutical company Hospira has acquired worldwide rights to a biogeneric version of Amgen's neutropenia treatment Neupogen (filgrastim) in a …
GSK’s Avodart tackles BPH better in combination
October 14, 2009Research and Development, Sales and Marketing GSK, bph, urology
GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …
Green light at Angelini plant resurrects antidepressant prospects
October 13, 2009Manufacturing and Production Angelini
Canadian drugmaker Labopharm has been boosted by the news that manufacturing problems holding up approval of its novel antidepressant product, …
Oakley launches Oxygen Health
October 13, 2009Medical Communications Oxygen, PR, hc
Oxygen Health, an agency aiming to help pharma companies communicate more effectively with stakeholders, has launched.It has been set up …
Contract research news in brief
October 13, 2009Research and Development CRO
Pharmafocus' latest round-up of contract research news includes another CRO heading into private equity hands, changing requirements for the clinicaltrials.gov …
GSK expands in China with vaccine joint venture
October 12, 2009Sales and Marketing China, GSK, vaccines
GSK has joined with Chinese biotech Jiangsu Walvax to develop and manufacture paediatric vaccines for use in China.The pair will …
FDA revises cancer vaccine guidance
October 12, 2009Sales and Marketing Cancer, US, reg, vacccine
There are concerns that draft guidance from the US Food and Drug Administration, which will recommend that cancer vaccine trials …
Personal health budget pilots to be assessed
October 12, 2009Sales and Marketing NHS, hc
The success or otherwise of personal health budgets is to be assessed in a study on their benefits across 20 …
Digital Pharma: GSK pushes patient information boundaries
October 12, 2009Medical Communications GSK, digi, digital pharma, patient information
GlaxoSmithKline has launched a product information website for patients in the UK, becoming the second major pharma company to push …
Montreal gets manufacturing boost from Schering-Plough
October 9, 2009Manufacturing and Production Canada, Merck
Schering-Plough says it is planning to invest more than C$30 million ($28 million) to expand a pharmaceutical manufacturing facility in …
Head-to-head trial favours Shire’s Fosrenol
October 8, 2009Research and Development, Sales and Marketing fosrenol, renal
Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …
Simponi approved in Europe
October 8, 2009Sales and Marketing RA, Simponi, TNF
Rheumatic disease drug Simponi has received marketing approval for Europe, where it will be marketed by Schering-Plough.The drug is indicated …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
